Nanobiotix
NANO | PA
Overview
Corporate Details
- ISIN(s):
- FR0010102145 (+2 more)
- LEI:
- 969500667RSYIH8YL895
- Country:
- France
- Address:
- 60 RUE DE WATTIGNIES, 75012 PARIS
- Website:
- https://www.nanobiotix.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is one rooted in designing pioneer physical based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. Nanobiotix’s novel first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Furthermore, Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-11 11:29 |
Major Shareholding Notification
Franchissements de seuils
|
French | 111.3 KB | |
| 2025-07-11 11:18 |
Major Shareholding Notification
Franchissement de seuils
|
French | 123.4 KB | |
| 2025-07-11 11:11 |
Major Shareholding Notification
Franchissement de seuils
|
French | 122.5 KB | |
| 2025-06-20 15:17 |
Major Shareholding Notification
Franchissement de seuils
|
French | 123.1 KB | |
| 2025-06-20 15:07 |
Major Shareholding Notification
Franchissement de seuils
|
French | 123.4 KB | |
| 2025-06-10 22:15 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total de droits de vote et d’actions c…
|
French | 110.8 KB | |
| 2025-06-10 22:15 |
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
|
English | 112.0 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
NANOBIOTIX participera à la conférence investisseurs annuelle Jefferies Global …
|
French | 91.4 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference
|
English | 88.9 KB | |
| 2025-05-21 22:15 |
Regulatory News Service
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
|
English | 173.9 KB | |
| 2025-05-21 22:15 |
Earnings Release
Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du p…
|
French | 194.9 KB | |
| 2025-05-14 08:00 |
Declaration of Voting Results & Voting Rights Announcements
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS C…
|
French | 110.7 KB | |
| 2025-05-14 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
|
English | 112.2 KB | |
| 2025-05-12 08:00 |
Regulatory News Service
Nanobiotix participera à la 3ème conférence investisseurs annuelle H.C. Wainwri…
|
French | 91.9 KB | |
| 2025-05-12 08:00 |
Regulatory News Service
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investo…
|
English | 89.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-11 | N/A | Other | Other | 959,060 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |